Fluoride in serum and bone during treatment of osteoporosis with sodium fluoride, calcium and vitamin D. 1982

R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks

Thirteen patients with primary osteoporosis were treated for two years with sodium fluoride (NaF), calcium and dihydrotachysterol (group A). The dose of NaF was modified according to the serum fluoride concentration, which was kept as constant as possible between 0.20 and 0.25 microgram/ml. In patients with bone fluoride content greater than or equal to 0.20% a significant increase in the volumetric density and in the surface percentage covered with osteoid and with osteoblasts was observed. A second group of 7 patients with primary osteoporosis was also treated for 2 years with calcium and dihydrotachysterol, but without fluoride (group B). In these patients no significant change in the volumetric density or in the surface percentage covered with osteoid or osteoblasts was found. Patients in group A with a bone fluoride content less than 0.20% could not be distinguished from the patients in group B. Based on the available data an advice was given for the dosage of NaF in patients with osteoporosis. Regular assessment of the serum fluoride concentration remains advisable.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D005459 Fluorides Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Sodium and stannous salts are commonly used in dentifrices. Fluoride
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
January 1987, Mineral and electrolyte metabolism,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
July 1981, The Orthopedic clinics of North America,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
October 1980, British medical journal,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
December 1971, The Journal of laboratory and clinical medicine,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
July 1972, The American journal of medicine,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
December 1980, Revue du rhumatisme et des maladies osteo-articulaires,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
May 1977, Calcified tissue research,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
July 1985, Schweizerische medizinische Wochenschrift,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
January 2005, Zeitschrift fur Orthopadie und ihre Grenzgebiete,
R G van Kesteren, and S A Duursma, and W J Visser, and J van der Sluys Veer, and O Backer Dirks
December 1986, Ugeskrift for laeger,
Copied contents to your clipboard!